Orthostatic hypotension (OH) is a well-known risk factor for falls, syncope, cardiovascular (CV) events, and mortality. [1] [2] [3] [4] Certain studies also report an association of orthostatic hypertension (OHT) with CV disease (CVD) risk. [5] [6] [7] The OH-and OHT-related CV risk may depend on the OH-and OHTrelated atherosclerosis risk. OH has been associated with conventional CV risk factors, including hypertension, 2, 3, 8, 9 diabetes mellitus, 3, 8, 9 age, 2,3,8-10 body mass index (BMI), 3, 8, 9 and a number of drugs. Although hypertension has been recognized as a risk factor for OHT, 11, 12 it is still unclear whether OH and OHT are associated with hypertension-caused target organ damage (TOD), such as left ventricular hypertrophy (LVH) and decreased estimated glomerular filtration rate (eGFR), which are well-known risk factors for premature CV events or death. The K/DOQI clinical practice guideline for chronic kidney disease suggests an eGFR <90 ml/(min·1.73m 2 ) as a decrease in eGFR in hypertensives. 13 Even a small decrease in eGFR reportedly increases CV risk. 14 Hypertension promotes peripheral artery disease (PAD) in combination with other atherosclerotic risk factors, including cigarette smoking, diabetes, and dyslipidemia. PAD is an important marker of atherosclerosis because of its association with CV ischemic events and all-cause mortality, especially in hypertensive patients. 15 Although hypertensive patients are predisposed to both CV complications and orthostatic blood pressure (BP) disorders (OH and OHT), there are still no adequate data on these relative contributions to CVD or TOD in hypertensive patients.
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Orthostatic hypotension (OH) is a well-known risk factor for falls, syncope, cardiovascular (CV) events, and mortality. [1] [2] [3] [4] Certain studies also report an association of orthostatic hypertension (OHT) with CV disease (CVD) risk. [5] [6] [7] The OH-and OHT-related CV risk may depend on the OH-and OHTrelated atherosclerosis risk. OH has been associated with conventional CV risk factors, including hypertension, 2, 3, 8, 9 diabetes mellitus, 3, 8, 9 age, 2, 3, [8] [9] [10] body mass index (BMI), 3, 8, 9 and a number of drugs. Although hypertension has been recognized as a risk factor for OHT, 11, 12 it is still unclear whether OH and OHT are associated with hypertension-caused target organ damage (TOD), such as left ventricular hypertrophy (LVH) and decreased estimated glomerular filtration rate (eGFR), which are well-known risk factors for premature CV events or death. The K/DOQI clinical practice guideline for chronic kidney disease suggests an eGFR <90 ml/(min·1.73m 2 ) as a decrease in eGFR in hypertensives. 13 Even a small decrease in eGFR reportedly increases CV risk. 14 Hypertension promotes peripheral artery disease (PAD) in combination with other atherosclerotic risk factors, including cigarette smoking, diabetes, and dyslipidemia. PAD is an important marker of atherosclerosis because of its association with CV ischemic events and all-cause mortality, especially in hypertensive patients. 15 Although hypertensive patients are predisposed to both CV complications and orthostatic blood pressure (BP) disorders (OH and OHT), there are still no adequate data on these relative contributions to CVD or TOD in hypertensive patients.
We hypothesized that both OH and OHT are closely associated with TOD and CVD in hypertensive patients. To test this hypothesis, a community-based cross-sectional study was conducted to evaluate the following: (i) the prevalence of OHT and OH in treated/untreated hypertensives and normotensives; (ii) the association of orthostatic BP disorders with CVD or TOD in hypertensive patients.
METhOdS
Study population. The study was conducted in Xinyang County, China, from 2004 to 2005. The method details and the PAD prevalence have been published elsewhere. 16 Briefly, a multistage cluster sampling method was used to select a representative sample of rural community residents, aged 40-75 years. Hypertension was defined as systolic BP (SBP) and/or diastolic BP (DBP) of ≥140/90 mm Hg, or current medication for hypertension (World Health Organization (WHO) 1999 criteria). A flow chart is shown (Figure 1) . Finally, 4,711 hypertensive patients as well as 826 normotensives with SBP and/or DBP <130/85 mm Hg and without a family history of hypertension were enrolled. Among the participants, 3,937 subjects were hypertensive patients (83.6%) with valid data on left ventricle echocardiographic measurements. We chose BP of 130/85 mm Hg as the cutoff for normotensives because subjects with BP >130/85 mm Hg have a relatively high risk to develop arterial hypertension within 10 years, according to Chinese epidemiological data. 17 This study was approved by the ethical committees of FuWai and local hospitals, and written informed consent was obtained from each subject before enrollment.
Data collection. Sociodemographic factors, medical history, and the status of cigarette smoking and alcohol consumption were obtained with a standardized questionnaire. Anthropometric measurements including body height (m), body weight (kg), and waist and hip circumference were determined. All subjects underwent a standard 12-lead electrocardiogram. Overnight fasting blood was drawn for assays of fasting blood glucose, total cholesterol (TC), triglycerides (TGs), high-density lipoprotein-cholesterol (HDL-C), low-density lipoprotein-cholesterol (LDL-C), serum uric acid, and creatinine levels by the core laboratory, FuWai hospital, Beijing, China. Obesity was defined as BMI ≥30.0 according to WHO criteria. 18 Metabolic syndrome was determined by the 2005 International Diabetes Federation criteria. Diabetes mellitus was ascertained based on fasting plasma glucose level ≥126 mg/dl or the reported use of a hypoglycemic medication. Dyslipidemia was diagnosed as any one of the following: TG >200 mg/dl; TC ≥240 mg/dl; LDL-C ≥160 mg/dl; or HDL-C <40 mg/dl, according to the Adult Treatment Panel III guideline. The use of antihypertensive agents was based on participants' self-report on the previous 8 weeks. "Untreated patients" were those who had never received or were not presently receiving antihypertensive drugs for a period of at least 8 weeks. "Treated patients" were currently receiving antihypertensive agents. Diuretics, calcium channel blockers, and angiotensin-converting enzyme inhibitors were commonly used antihypertensive medicines in this study population. Figure 1 | a flat chart for the study protocol. aBI, ankle-brachial blood pressure index; BP, blood pressure.
Measurement of BP and classification of orthostatic
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Orthostatic BP Disorders and Hypertensive TOD or CVD large, or thigh) fit to the subject's right arm. Three readings were recorded in the seated position at least 1-min apart after >5-min rest, and three readings on average were analyzed. All BP investigators had completed a training program and passed a test for BP measurement. The training program was adapted from the procedures recommended by the American Heart Association. 19 Supine and standing BP were recorded with a sphygmomanometer by a trained physician or nurse. After a 15-min electrocardiogram examination with the subject lying on an examination bed, supine measurements were taken three times at ~30-s intervals. Subjects were asked to stand from the supine position with the forearm relaxed and supported at heart level, and standing BP measurements were taken at 30 s as well as 2 min. OH was defined as a decline in SBP of ≥20 mm Hg and/ or a decline in DBP of ≥10 mm Hg after either 30 s or 2 min from a supine to upright posture. 20 The definition of OHT was an increase in the orthostatic SBP of ≥20 mm Hg. 21 The orthostatic SBP change was calculated from the average of two standing SBP readings minus the average of three supine SBP readings. Participants with neither of these two patterns were classified as normal orthostatic BP response (ONT).
Echocardiography. Echocardiograms were performed by two trained technicians using an HP 5500 (Philips, Boston, MA) or an HDI 3000 (ATL, Bothell, WA), each equipped with 2.5 and 3.5 MHz imaging transducers. A standardized protocol 22 was followed. Parasternal and apical acoustic windows were used to record 10 consecutive beats per projection. The left ventricular internal dimension, and interventricular septal and posterior BMI, body mass index; bpm, beats/min; CAD, coronary artery disease; DBP, diastolic blood pressure; DM, diabetes mellitus; eGFR, estimated glomerular filtration rate; FBG, fasting blood glucose; HR, heart rate; MS, metabolic syndrome; PP, pulse pressure; SBP, systolic blood pressure; Scr, serum creatinine. *P < 0.05 vs. normotensive controls; † P < 0.05 vs. untreated hypertensive patients. 
Orthostatic BP Disorders and Hypertensive TOD or CVD wall thickness were measured at end-diastole and end-systole according to the American Society of Echocardiography recommendation 23 of up to three cardiac cycles from two-dimensionally guided M-mode tracings, or linear measurements were derived from the two-dimensional study if the M-mode tracings were technically inadequate. All elements of the protocol were videotaped and re-evaluated by highly experienced readers. All the technicians and readers were unaware of the patient BP readings. The intraobserver coefficients of variation were 1.5-6.8% for the interventricular septum, posterior wall, internal diameter, and left ventricular mass. Left ventricular mass was calculated with the Penn convention and adjusted for body surface area. 24 LVH was considered present if the left ventricular mass index exceeded 125 g/m 2 in men or 110 g/m 2 in women. 25 Determination of CVD and TOD. Coronary artery disease (CAD) was ascertained using hospital records, a history of myocardial infarction, coronary revascularization, including percutaneous coronary intervention and coronary artery bypass graft, computed tomography or coronary angiography showing ≥50% luminal stenosis in one or more of the major epicardial arteries. Stroke was ascertained as rapidly developing clinical signs of neurological deficit and symptoms suggestive of subarachnoid hemorrhage, intracerebral hemorrhage, or cerebral ischemic infarction, as well as by brain imaging, including magnetic resonance imaging, computed tomography, and angiography. Of the patients with CAD or stroke, 81% were confirmed by imaging data. Ankle-brachial blood pressure index was determined by using a standard protocol with a portable Doppler device (ES-101EX; Smart Nine, Kawasaki, Japan). 16 PAD was ascertained if either of the two leg ankle-brachial blood pressure index was ≤0.9. The estimated eGFR was calculated using the Modification of Diet in Renal Disease Study equation: 186.3 × (serum creatinine) −1.154 × age −0.203 × (0.742 for women) and the decreased eGFR was defined as <90 ml/(min·1.73m 2 ). 13 An events committee evaluated the CVD and TOD, and the data quality was monitored by an independent quality control committee. The members of both committees were blinded to the BP categories of the patients. 
Statistical analysis. The t-test
0.14
Boldface values denote statistical significance. BMI, body mass index; BP, blood pressure; CI, confidence interval; DBP, diastolic blood pressure; DM, diabetes mellitus; ECHO-LVH, left ventricular hypertrophy diagnosed by echocardiography; eGFR, estimated glomerular filtration rate; MS, metabolic syndrome; N1, number of the whole studied subjects; N2, number of subjects with valid data on left ventricular measurements; OH, orthostatic hypotension; OHT, orthostatic hypertension; ONT, normal orthostatic blood pressure change; OR, odds ratio; PAD, peripheral artery disease; SBP, systolic blood pressure. a Using multiple logistic regression analysis adjusted for age, BMI, sex, supine systolic and diastolic BP, supine heart rates, diabetes, metabolic syndrome, dyslipidemia, and antihypertensive treatment. b After adjustment for confounders by using multiple logistic regression analysis. *P < 0.05 vs. ONT group before adjustment for confounders. and treated hypertensive patients. the odds ratios (95% confidence interval (CI)) for PaD: (0, patients without PaD; 1, patients with PaD) were adjusted for age, sex, BMI, supine systolic and diastolic BP, supine heart rates, and other conventional risk factors by using a binary logistic regression analysis (Q3, the reference group). BMI, body mass index; BP, blood pressure.
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Orthostatic BP Disorders and Hypertensive TOD or CVD SBP changes on LVH was analyzed by sex with adjustment for treatment status because (i) the criteria for diagnosis of LVH is different between men (left ventricular mass index >125 g/ m 2 ) and women (>110 g/m 2 ); (ii) the prevalence of LVH and cardiac adaptation to pressure overload displays a significant sex-related difference in humans 26, 27 and in animal models; 28 (iii) the prevalence of LVH was significantly higher in women than in men (39.6% vs. 49.2%, P < 0.001) in our study. A two-tailed P value of <0.05 was considered significant.
RESulTS
Prevalence of OhT and Oh in hypertensives and normotensives
The baseline clinical characteristics are shown in Table 1 .
Hypertensive patients had higher seated BP and prevalence of most of the risk factors than did the normotensive controls. Supplementary Figure S1 shows the distribution of the orthostatic SBP response in hypertensives and normotensives. The prevalence of OHT or OH was higher in hypertensives (treated or untreated) than in normotensives (P < 0.01) (Figure 2) . However, no significant difference was observed in OH between the treated and untreated patients (P = 0.09) (Figure 2) , or between the untreated and patients treated with each of the three classes of antihypertensive medicine, including diuretics, calcium channel blockers, and inhibitors of angiotensin-converting enzyme (Supplementary Figure S2) , after adjustment for age, sex, and BMI. To further exclude the effects of CVD or diabetes mellitus on orthostatic BP regulation, an analysis was conducted in a subset of subjects without stroke, CAD, or diabetes mellitus (treated patients n = 883, untreated patients n = 3,103, and normotensive controls n = 755), with similar results (OHT: 18.1% in treated and 16.2% in untreated vs. 8.9% in normotensives, both P < 0.001; OH: 22.7% in treated and 22.8% in untreated vs. 14.6% in normotensives, both P < 0.001).
After adjustment for age, sex, BMI, supine SBP and DBP, the difference between hypertensives and normotensives remained significant in OHT (untreated patients: OR, 2.34, 95% CI 1.75-3.14; treated patients: OR, 3.15, 95% CI 2.11-4.72). However, the difference disappeared in OH (untreated patients: OR, 1.03, 95% CI 0.81-1.30; treated patients: OR, 0.92, 95% CI 0.65-1.31) after adjustment for supine SBP and DBP (Supplementary Table S1 ). and in male hypertensive patients. the odds ratios (95% confidence interval (CI)) for LVH: (0, patients without LVH; 1, patients with LVH) were adjusted for age, BMI, supine systolic and diastolic BP, supine heart rates, antihypertensive treatment, and other conventional risk factors by using a binary logistic regression analysis (Q3, the reference group). BMI, body mass index; BP, blood pressure. Boldface values denote statistical significance. BP, blood pressure; ΔSBP, the average of standing systolic blood pressure − the average of supine systolic blood pressure; CAD, coronary artery disease; CI, confidence interval; OH, orthostatic hypotension; OHT, orthostatic hypertension; ONT, normal orthostatic blood pressure change; ORs, odds ratios. a After adjustment for age, sex, body mass index, supine systolic and diastolic BP, supine heart rates, and conventional risk factors by using multiple logistic regression analysis. b After adjustment for confounders by using multiple logistic regression analysis. *P < 0.01 vs. ONT group before adjustment for confounders; † P < 0.05 vs. Q3 group before adjustment for confounders.
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Selected clinical characteristics and orthostatic BP disorders in hypertensives or normotensives
Hypertensive patients with either OHT or OH were older, and had higher seated SBP and pulse pressure than ONT patients ( Table 2) . Patients with OH had lower BMI and supine heart rate than those with ONT. Both hypertensives and normotensives exhibited a similar pattern of BP response to posture change. After adjustment for age, sex, and other covariates, OH was positively associated with supine BP, but negatively associated with BMI, supine heart rate, and seated DBP, whereas OHT was positively associated with seated BP, but negatively associated with supine SBP in hypertensives (Supplementary Table S2 ). The adjusted OR remained significant between supine or seated BP, and OH as well as OHT in normotensives (Supplementary Table S3 ).
Orthostatic BP status, PAd, decreased egFR, and lVh in hypertensives PAD was more common in both the OHT and OH groups, whereas the decreased eGFR and LVH were more common in the OH than ONT group ( Table 3) . After adjustment for age, sex, BMI, supine SBP and DBP, and other conventional risk factors, both OH and OHT were still associated with PAD, as were age, BMI, and supine SBP; OH and female gender, but not OHT, were associated with LVH; neither OH nor OHT were associated with the decreased eGFR. Because the definitions for OHT and OH are somewhat arbitrary, we next empirically grouped hypertensive patients into quintiles (Q1-Q5) based on orthostatic SBP increase. After adjustment for demographics, and supine SBP and DBP, treatment status was found to be a confounder for the association of PAD with orthostatic SBP change. A J-shaped relationship was identified in the distribution of the adjusted ORs for PAD across the orthostatic SBP increase quintiles in the untreated, but not the treated hypertensive patients (Figure 3) . The association of LVH with orthostatic SBP drop (the bottom quintile) was found in both the treated and untreated patients. However, a J-shaped relationship was found only in women, even after adjustment for treatment status, revealing a sex difference in the association of LVH with the orthostatic SBP response (Figure 4) .
Orthostatic BP status, CAd, and stroke in hypertensives CAD and stroke were more common in OH patients, whereas stroke was also more common in OHT patients, than in those with ONT (all P < 0.01) ( Table 4) . After adjustment for age, sex, BMI, supine SBP and DBP, and conventional risk factors, both OHT and OH were associated with stroke, but only OH was associated with CAD. Further analyses confirmed the association of CAD with the orthostatic SBP drop (the bottom quintile), and stroke with both orthostatic SBP drop and orthostatic SBP increase (the top and bottom quintile) ( Table 4) . dISCuSSION In this community-based study, we found that both OH and OHT were more common in hypertensives than normotensives, but the difference in OH disappeared after adjustment for supine SBP and DBP. No differences were observed in OH between treated and untreated hypertensive patients after adjustment for age, sex, and BMI. A strong association independent of other known risk factors was identified between CVD/TOD and OH/OHT, as well as orthostatic SBP changes, in this large group of hypertensive patients.
Consistent with previous reports, 5, 8, 29 we found a high prevalence of OH and OHT in hypertensive patients. Low BMI and high supine SBP and DBP levels may also be risk factors for OH. The common occurrence of OH in hypertensive patients might be associated with relatively high supine SBP and DBP levels because the difference in OH disappeared after adjustment for SBP and DBP. The prevalence of OH and OHT varies between studies due to differences in definition, methodology, and population selection. 6, 11, 29, 30 Our findings, together with the previous studies, 4, 31 do not support the claim that commonly used antihypertensive drugs increase the risk of OH, even it is well accepted. However, because our results might be explained by the low BP controlling rate reached and relatively low dosage of drugs used in the study population, as well as racial differences 32 in the side effects of antihypertensive drugs, further prospective studies are needed to clarify the influence of antihypertensive drugs on OH.
The reported associations of orthostatic BP disorders with CVD and TOD remain controversial. Our findings not only confirmed the associations of OH with stroke, 2 LVH, 2 and CAD, 3 but also an association of OHT with stroke and PAD. Previous results have shown OHT to be associated with silent cerebrovascular disease, 6 high frequency of LVH, 6 and extreme dippers. 11 These results indirectly support that the stroke risk (extreme dippers are at high risk for stroke 33 ) may result from the risk caused by OHT. Our results were also consistent with previous findings that the prevalence of PAD exhibits a J-shape across deciles of orthostatic SBP increase in blacks (but not in whites). 5 In contrast to a previous report, 34 we did not find an association of impaired renal function with OH.
It is unclear whether orthostatic BP disorders are the result of TOD and CVD, or the opposite, i.e., orthostatic BP disorders result in TOD and CVD. Hypertension accelerates atherosclerosis and LVH, and reduces baroreflex sensitivity. 35 Hypertensive patients with TOD or CVD may have a decreased vascular compliance and severe vascular atherosclerosis, leading to autonomic nervous dysfunction and a predisposition to OH or OHT. Another possibility is that the frequent episodes of increased BP variability caused by OH or OHT 6,11 during daily activity may contribute to increased risk of TOD and/or CVD because BP variability increases the risk of both atherosclerosis and TOD due to the traumatic effect of wider BP swings on the vessel wall. 36, 37 The OHT recorded with home BP monitoring is associated with a increased level of B-type natriuretic peptide and a high ratio of urinary albumin/creatinine, 38 indicating that OHT is a high-risk factor for CV events independent of the seated BP. The nocturnal hypertension or elevated night-time BP, which is commonly observed in OH, is also associated with TOD and a worse CV original contributions Orthostatic BP Disorders and Hypertensive TOD or CVD prognosis. 39 Furthermore, prospective studies 1,2 have already confirmed the predictive effect of OH for CVD risk. Based on such observations, we considered that orthostatic BP disorders may not only indicate underlying abnormalities of the autonomic nervous system, but also serve as risk factors for TOD as well as CVD in hypertensive patients. The sex effect on pressure-overload LVH 27 may be responsible, at least in part, for the sex difference shown in the association between orthostatic SBP changes and LVH.
Most studies have focused on OH in community dwellers and elderly populations, and our large sample size study may provide helpful additional information on OH and OHT in community-based hypertensive patients. However, this crosssectional study design has the limitation of being unable to distinguish the causality or outcome between orthostatic BP disorders and TOD/CVD. Our study did not include the data of heart rate orthostatic response, which might be helpful information in determining the cause of OH. However, heart rate has not been reportedly included as an assessment parameter in the definition of OH.
In conclusion, OH is associated with CV risk; the associations of OHT with TOD and stroke in hypertensive patients still need to be confirmed in prospective studies. 
